Further characterization of the PKG pathway in Drosophila and the translation of potential pathway therapeutics to mammals could provide a novel treatment for the prevention of brain damage in humans, who experience trauma in a wide variety of settings, such as stroke, drowning, febrile seizures, and epilepsy, in addition to hyperthermia. This evidence concerns the gene PRKG1 and stroke disorder.